The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Joins Opposition to Proposed Healthcare Replacement Bill as Written

ACR Joins Opposition to Proposed Healthcare Replacement Bill as Written

March 16, 2017 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR is joining a chorus of voices asking Congress to reconsider several key provisions in the proposed American Health Care Act (AHCA) that it feels could have a detrimental effect on patients.

You Might Also Like
  • ACR: Senate Healthcare Bill Falls Short of Protecting Americans Living with Rheumatic Diseases
  • Congress Reveals Proposed ACA Replacement
  • Senate Republicans Unveil Obamacare Replacement Bill with Tough Debate Expected
Also By This Author
  • PR-COIN Initiative Takes Aim at Juvenile Idiopathic Arthritis

Characterized as a replacement to the Affordable Care Act (ACA), the AHCA eliminates a number of provisions found in the ACA, although it does retain some of the ACA’s most popular provisions.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

 Major Concern: Access to Care
Like other medical groups, the ACR is glad to see several of the ACA’s most popular provisions are not repealed by the AHCA, such as no exclusions for coverage based on pre-existing conditions and coverage for children up to age 26 on their parents’ insurance.

“We are concerned that some provisions of the AHCA could make it harder for our patients to access rheumatology care,” said Sharad Lakhanpal, MBBS, MD, president of the ACR, in a statement issued on March 9.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

These provisions include replacing income-based subsidies under the ACA with fixed tax credits based on age rather than income, as well as imposing a 30% penalty on premiums for patients who lose coverage for more than 63 days.

Other Concerns: Access to Medication, Capping Medicaid
Expanding on those concerns, Angus Worthing, MD, chair of the ACR’s Government Affairs Committee, underscored that many patients under the proposed replacement bill could lose access to lifesaving and life-altering drugs, such as biologics. “These are virtually unaffordable without insurance,” he says.

Dr. Worthing also highlights concerns expressed by pediatric rheumatologists that the proposed bill would remove federal guarantees for Medicaid payments. Under the AHCA, states would be given a set amount of money per person (per capita cap) to spend on Medicaid recipients starting in 2020; this amount would grow yearly to account for inflation.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

However, setting a cap on Medicaid dollars under such a formula is problematic. “Healthcare costs may increase faster than the proposed per capita Medicaid funding and leave poor children and families without coverage,” says Dr. Worthing.

Physician & Patient Groups Weigh In
In addition to the ACR, other medical groups have expressed concerns, including the American Medical Association (AMA), the American Hospital Association, the American College of Physicians (ACP), the American Association of Retired Persons (AARP) and most medical specialty groups.

In a statement issued on March 8, the AMA also highlighted concerns over the use of tax credits based on age rather than income for obtaining private health insurance coverage, as well as changes to Medicaid that could limit states’ ability to adequately cover low-income families, for example, changes to services needed for chronic conditions, such as mental health and substance abuse, as well as ongoing problems, such as opioid abuse and addiction.2, 3

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: Access to care, Access to medication, Affordable Care Act (ACA), American Association of Retired Persons, American Health Care Act (AHCA), American Medical Association (AMA), Capping Medicaid, healthcare provisions, Prevention and Public Health Fund

You Might Also Like:
  • ACR: Senate Healthcare Bill Falls Short of Protecting Americans Living with Rheumatic Diseases
  • Congress Reveals Proposed ACA Replacement
  • Senate Republicans Unveil Obamacare Replacement Bill with Tough Debate Expected
  • State Funding Changes in Spotlight in U.S. Republican Healthcare Bill

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)